NCT01639911 2019-07-22Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsUniversity of Illinois at ChicagoPhase 1 Completed28 enrolled
NCT01012362 2017-12-28Study of Pazopanib and Ixabepilone in Patients With Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Terminated31 enrolled 12 charts